Survivin anticorps (Internal Region)
-
- Antigène Voir toutes Survivin (BIRC5) Anticorps
- Survivin (BIRC5) (Baculoviral IAP Repeat-Containing 5 (BIRC5))
-
Épitope
- Internal Region
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Survivin est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificité
- Survivin Antibody detects endogenous levels of total Survivin.
- Homologie
- Pig,Bovine,Horse,Sheep,Dog
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human Survivin, corresponding to a region within the internal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product BIRC5 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
-
Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance." dans: Cell death & disease, Vol. 9, Issue 4, pp. 419, (2018) (PubMed).
: "
-
Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance." dans: Cell death & disease, Vol. 9, Issue 4, pp. 419, (2018) (PubMed).
-
- Antigène
- Survivin (BIRC5) (Baculoviral IAP Repeat-Containing 5 (BIRC5))
- Autre désignation
- BIRC5 (BIRC5 Produits)
- Synonymes
- anticorps AP14, anticorps API4, anticorps EPR-1, anticorps AAC-11, anticorps Api4, anticorps TIAP, anticorps survivin40, anticorps bir5a, anticorps survivin, anticorps BIR1, anticorps Su2, anticorps XBIR1, anticorps XSurvivin1, anticorps Xsvv1, anticorps api4, anticorps bir1-A, anticorps epr-1, anticorps svv1, anticorps xSurvivin, anticorps xsurv, anticorps Su1, anticorps birc5.2, anticorps svv2, anticorps xSurvivin2, anticorps bir5b, anticorps SIX, anticorps birc5.2-a, anticorps birc5.2-b, anticorps baculoviral IAP repeat containing 5, anticorps baculoviral IAP repeat-containing 5, anticorps baculoviral IAP repeat containing 5a, anticorps baculoviral IAP repeat-containing 5, gene 1 L homeolog, anticorps baculoviral IAP repeat containing 5 L homeolog, anticorps baculoviral IAP repeat containing 5b, anticorps baculoviral IAP repeat containing 5 S homeolog, anticorps BIRC5, anticorps Birc5, anticorps birc5a, anticorps birc5.1.L, anticorps birc5.2.L, anticorps birc5b, anticorps birc5.2.S
- Sujet
-
Description: Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:9859993, PubMed:21364656, PubMed:20627126). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (PubMed:16322459). Acts as an important regulator of the localization of this complex, directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules (PubMed:20826784). Involved in the recruitment of CPC to centromeres during early mitosis via association with histone H3 phosphorylated at 'Thr-3' (H3pT3) during mitosis (PubMed:20929775). The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules (PubMed:18591255). May counteract a default induction of apoptosis in G2/M phase (PubMed:9859993). The acetylated form represses STAT3 transactivation of target gene promoters (PubMed:20826784). May play a role in neoplasia (PubMed:10626797). Inhibitor of CASP3 and CASP7 (PubMed:21536684). Isoform 2 and isoform 3 do not appear to play vital roles in mitosis (PubMed:12773388, PubMed:16291752). Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform (PubMed:10626797).
Gene: BIRC5
- Poids moléculaire
- 20kDa
- ID gène
- 332
- UniProt
- O15392
- Pathways
- Apoptose, Cycle Cellulaire, Nuclear Hormone Receptor Binding
-